Treatment for macrophage activation syndrome associated with systemic juvenile idiopathic arthritis in Japan.

Masaki ShimizuKenichi NishimuraNaomi IwataTakahiro YasumiHiroaki UmebayashiYasuo NakagishiYuka OkuraNami OkamotoNoriko KinjoMao MizutaMasato YashiroJunko YasumuraHiroyuki WakiguchiTomohiro KubotaMariko MouriUtako KanekoMasaaki Mori

Published in: International journal of rheumatic diseases (2023)

The first-line treatment for MAS in Japan is mPSL pulse therapy and/or CyA. DEX-P could be an effective and safe therapeutic option for patients with corticosteroid-resistant MAS.

Keyphrases

juvenile idiopathic arthritis
blood pressure
adipose tissue
disease activity
case report
mesenchymal stem cells
rheumatoid arthritis
cell therapy